WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012112420) TREATMENTS USING PSMA LIGAND ENDOPEPTIDASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/112420    International Application No.:    PCT/US2012/024818
Publication Date: 23.08.2012 International Filing Date: 13.02.2012
IPC:
C07K 14/33 (2006.01), A61K 38/16 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive Irvine, California 92612 (US) (For All Designated States Except US).
JACKY, Birgitte P.S. [DK/US]; (US) (For US Only).
GARAY, Patton E. [US/US]; (US) (For US Only).
MOLINA, Yanira [US/US]; (US) (For US Only).
FRANCIS, Joseph [CA/US]; (US) (For US Only).
STEWARD, Lance E. [US/US]; (US) (For US Only).
GHANSHANI, Sanjiv [US/US]; (US) (For US Only).
HUNT, Terrence J. [US/US]; (US) (For US Only).
SACHS, George [US/US]; (US) (For US Only).
AOKI, Roger, K. [US/US]; (US) (For US Only).
Fernandez-Salas, Ester [US/US]; (US) (For US Only)
Inventors: JACKY, Birgitte P.S.; (US).
GARAY, Patton E.; (US).
MOLINA, Yanira; (US).
FRANCIS, Joseph; (US).
STEWARD, Lance E.; (US).
GHANSHANI, Sanjiv; (US).
HUNT, Terrence J.; (US).
SACHS, George; (US).
AOKI, Roger, K.; (US).
Fernandez-Salas, Ester; (US)
Agent: ABEL, Kenton B.; ALLERGAN, INC. 2525 Dupont Drive Irvine, California 92612 (US)
Priority Data:
61/442, 757 14.02.2011 US
Title (EN) TREATMENTS USING PSMA LIGAND ENDOPEPTIDASES
(FR) TRAITEMENTS REPOSANT SUR L'UTILISATION D'ENDOPEPTIDASES DE LIGAND D'ANTIGÈNE DE MEMBRANE SPÉCIFIQUE DE LA PROSTATE (PSMA)
Abstract: front page image
(EN)The present specification discloses TVEMPs, compositions comprising such TVEMPs and methods of treating a prostate cancer, a benign prostatic hyperplasia, and/or neovascularization or pathological angiogenesis associated with a cancer in a mammal using such TVEMP compositions.
(FR)La présente invention concerne des protéines modulatrices de l'exocytose vésiculaire ciblées (TVEMP), des compositions contenant ces TVEMP et des méthodes permettant de traiter le cancer de la prostate, l'hyperplasie prostatique bénigne et/ou la néovascularisation ou l'angiogenèse pathologique associées à un cancer chez un mammifère, à l'aide de ces compositions à base de TVEMP.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)